Verastem, Inc. (LON:0LOV)
London · Delayed Price · Currency is GBP · Price in USD 7.90
+0.11 (1.45%)
At close: Jan 9, 2026
Verastem Market Cap
Verastem has a market cap or net worth of 448.5 million as of January 9, 2026. Its market cap has increased by 218.47% in one year.
Market Cap
448.50M
Enterprise Value
412.52M
Revenue
9.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.90
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from 142.97M to 448.50M, an increase of 213.69%. That is a compound annual growth rate of 8.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 448.50M | 1.31% |
| Dec 31, 2025 | 442.71M | 140.87% |
| Dec 31, 2024 | 183.80M | 13.82% |
| Dec 29, 2023 | 161.48M | 130.08% |
| Dec 30, 2022 | 70.18M | -74.56% |
| Dec 31, 2021 | 275.82M | 4.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.86B |
| GSK plc | 75.87B |
| Haleon | 33.12B |
| Smith & Nephew | 10.66B |
| Convatec Group | 4.73B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.72B |